MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1

被引:45
|
作者
Tao, Jun [1 ]
Cong, Haibo [2 ]
Wang, Hongyan [2 ]
Zhang, Daoqiang [2 ]
Liu, Chuanjie [2 ]
Chu, Hongxia [2 ]
Qing, Qianfeng [2 ]
Wang, Kunzheng [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Orthoped, Xian 710004, Shaanxi, Peoples R China
[2] Weihai Cent Hosp, Weihai City Key Lab Autoimmun, Weihai 264400, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteosarcoma; FOXD1; miR-30a-5p; Cell proliferation; Cell migration; BREAST-CANCER; GROWTH; SUPPRESSES; APOPTOSIS; MICRORNAS; PROGNOSIS; GENETICS; STAND;
D O I
10.1016/j.bbrc.2018.06.121
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite a number of studies have emphasized the extensive role of microRNA (miRNA) in the development of multiple cancers, the role of miR-30a-5p in the progression of osteosarcoma (OS) and the underlying mechanism are still limited. We detected the expression level of MiR-30a-5p and forkhead box D1 (FOXD1) in Clinical OS specimens and found that miR-30a-5p was significantly decreased while FOXD1 was markedly increased. Dual luciferase assay confirmed that FOXD1 was directly regulated by miR-30a-5p. In vitro assay showed that inhibitior of FOXD1 suppressed cell proliferation, migration and invasion in MG63 and U2OS cells, while overexpression of FOXD1 promoted OS cell proliferation and migration. In vivo assay further showed the inhibition of tumor growth after knockdown of FOXD1. These results suggested that FOXD1 might play key roles in OS development and progression, and was negatively regulated by miR-30a-5p in OS. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:1092 / 1097
页数:6
相关论文
共 50 条
  • [21] MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation and migration
    Xiong, Jiaxiu
    Wei, Bo
    Ye, Qinong
    Liu, Wenzhong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 516 (03) : 1013 - 1018
  • [22] miR-223-5p targeting ERG inhibits prostate cancer cell proliferation and migration
    Wei, Yongbao
    Peng, Junming
    He, Shuyun
    Huang, Haijian
    Lin, Le
    Zhu, Qingguo
    Ye, Liefu
    Li, Tao
    Zhang, Xing
    Gao, Yun-Liang
    Zheng, Xiaochun
    JOURNAL OF CANCER, 2020, 11 (15): : 4453 - 4463
  • [23] RETRACTION: miR-30a-5p inhibits the proliferation, migration and invasion of melanoma cells by targeting SOX4 (Retraction of Vol 18, Pg 2492, 2018)
    Liu, Erbiao
    Sun, Xiyan
    Li, Jinping
    Zhang, Chao
    MOLECULAR MEDICINE REPORTS, 2023, 28 (04)
  • [24] MiR-217 Inhibits Proliferation, Migration, and Invasion by Targeting SIRT1 in Osteosarcoma
    He, Shaoxuan
    Wang, Zhihua
    Tang, Hao
    Dong, Junjie
    Qu, Yongzhou
    Lv, Jia
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (04) : 264 - 270
  • [25] miR-202-5p inhibits the migration and invasion of osteosarcoma cells by targeting ROCK1
    Li, Congda
    Ma, Deying
    Yang, Jinhu
    Lin, Xiangbo
    Chen, Bo
    ONCOLOGY LETTERS, 2018, 16 (01) : 829 - 834
  • [26] RETRACTION: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1 (Retraction of Vol 17, Pg 253, 2021)
    Zhang, D.
    Zhang, Y.
    Sun, X.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (06) : 762 - 762
  • [27] miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN
    He, Ming
    Shen, Peng
    Qiu, Chuang
    Wang, Jiashi
    AGING-US, 2019, 11 (15): : 5744 - 5756
  • [28] MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR
    Liu, Yang
    Zhu, Shu-Tao
    Wang, Xiao
    Deng, Jun
    Li, Wei-Hua
    Zhang, Peng
    Liu, Bing-Shan
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (05) : NP40 - NP48
  • [29] FOXD1 promotes proliferation, migration, and epithelial-mesenchymal transformation in esophageal squamous cell carcinoma by targeting SNAI1
    Wu, Zheng
    Li, Wen
    Zhu, Hui
    Guo, Shenghu
    Zhang, Yuehua
    Zhang, Lei
    Guo, Xiaojin
    Cao, Jing
    Wang, Zhiyu
    PROCESS BIOCHEMISTRY, 2024, 138 : 47 - 56